Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Medical University of South Carolina, Charleston, SC, USA.
Lancet Microbe. 2024 Jun;5(6):e520-e528. doi: 10.1016/S2666-5247(24)00001-6. Epub 2024 Apr 9.
Xpert MTB/RIF Ultra (Ultra) is an automated molecular test for the detection of Mycobacterium tuberculosis in sputum. We compared the sensitivity of Ultra to that of mycobacterial growth indicator tube (MGIT) liquid culture, considered the most sensitive assay in routine clinical use.
In this prospective, multicentre, cross-sectional diagnostic accuracy study, we used a non-inferiority design to assess whether the sensitivity of a single Ultra test was non-inferior to that of a single liquid culture for detection of M tuberculosis in sputum. We enrolled adults (age ≥18 years) with pulmonary tuberculosis symptoms in 11 countries and each adult provided three sputum specimens with a minimum volume of 2 mL over 2 days. Ultra was done directly on sputum 1, and Ultra and MGIT liquid culture were done on resuspended pellet from sputum 2. Results of MGIT and solid media cultures done on sputum 3 were considered the reference standard. The pre-defined non-inferiority margin was 5·0%.
Between Feb 18, 2016, and Dec 4, 2019, we enrolled 2906 participants. 2600 (89%) participants were analysed, including 639 (25%) of 2600 who were positive for tuberculosis by the reference standard. Of the 2357 included in the non-inferiority analysis, 877 (37%) were HIV-positive and 984 (42%) were female. Sensitivity of Ultra performed directly on sputum 1 was non-inferior to that of sputum 2 MGIT culture (MGIT 91·1% vs Ultra 91·9%; difference -0·8 percentage points; 95% CI -2·8 to 1·1). Sensitivity of Ultra performed on sputum 2 pellet was also non-inferior to that of sputum 2 MGIT (MGIT 91·1% vs Ultra 91·9%; difference -0·8 percentage points; -2·7 to 1·0).
For the detection of M tuberculosis in sputum from adults with respiratory symptoms, there was no difference in sensitivity of a single Ultra test to that of a single MGIT culture. Highly sensitive, rapid molecular approaches for M tuberculosis detection, combined with advances in genotypic methods for drug resistance detection, have potential to replace culture.
US National Institute of Allergy and Infectious Diseases.
Xpert MTB/RIF Ultra(Ultra)是一种用于检测痰液中结核分枝杆菌的自动化分子检测方法。我们比较了 Ultra 与分枝杆菌液体培养物(MGIT)的灵敏度,MGIT 被认为是常规临床使用中最敏感的检测方法。
在这项前瞻性、多中心、横断面诊断准确性研究中,我们采用非劣效性设计来评估单次 Ultra 检测的灵敏度是否不劣于单次 MGIT 液体培养物用于检测痰液中的结核分枝杆菌。我们招募了 11 个国家的有肺结核症状的成年人(年龄≥18 岁),每个成年人在两天内提供了至少 2 毫升的三份痰液样本。Ultra 直接在痰液 1 上进行,Ultra 和 MGIT 液体培养物在痰液 2 的悬浮沉淀上进行。MGIT 和固体培养基培养物在痰液 3 上的结果被认为是参考标准。预先设定的非劣效性边界为 5.0%。
在 2016 年 2 月 18 日至 2019 年 12 月 4 日期间,我们共招募了 2906 名参与者。对 2600 名(89%)参与者进行了分析,其中 639 名(25%)参与者按参考标准被诊断为结核病阳性。在包括的 2357 名非劣效性分析参与者中,877 名(37%)为 HIV 阳性,984 名(42%)为女性。直接在痰液 1 上进行的 Ultra 的灵敏度不劣于痰液 2 MGIT 培养物(MGIT 91.1%比 Ultra 91.9%;差值为-0.8%;95%CI-2.8 至 1.1)。在痰液 2 沉淀上进行的 Ultra 的灵敏度也不劣于痰液 2 MGIT(MGIT 91.1%比 Ultra 91.9%;差值为-0.8%;-2.7 至 1.0)。
对于有呼吸道症状的成年人痰液中结核分枝杆菌的检测,单次 Ultra 检测与单次 MGIT 培养物的灵敏度无差异。高灵敏度、快速的结核分枝杆菌分子检测方法,结合基因型耐药检测方法的进步,有可能取代培养。
美国国家过敏和传染病研究所。